Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A

ClinicalTrials.gov ID: NCT07830732

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT07830732. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 19, 2026, 2:04 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multinational, Open-label Study to Investigate Efficacy and Safety of Denecimig (Mim8) in Adults With Acquired Haemophilia A

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to find out if denecimig is safe and effective for treating people who have acquired haemophilia A. Participants will be in this study for up to around 1 year and 5 months (73 week).

Study identification

NCT ID
NCT07830732
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novo Nordisk A/S
Industry
Enrollment
84 participants

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 16, 2026 (Actual)
Primary completion
Mar 23, 2029 (Estimated)
Completion
Mar 23, 2029 (Estimated)
Last update posted
Oct 28, 2026

2026 – 2029

United States locations

U.S. sites
18
U.S. states
12
U.S. cities
18
Facility City State ZIP Site status
University of Iowa_Iowa City Iowa City Iowa 52242 Not yet recruiting
Tulane University School of Medicine Metairie Louisiana 70001 Not yet recruiting
University of Minnesota Minneapolis Minnesota 55455 Not yet recruiting
Mayo Clinic Rochester Minnesota 55905 Not yet recruiting
Washington University St Louis Missouri 63110 Recruiting
University of North Carolina Chapel Hill North Carolina 27614 Not yet recruiting
Duke University_Durham Durham North Carolina 27710 Not yet recruiting
University of Oklahoma Health Oklahoma City Oklahoma 73104 Not yet recruiting
Penn State MS Hershey Med Ctr Hershey Pennsylvania 17033-2360 Not yet recruiting
Univ of Pennsylvania Hospital Philadelphia Pennsylvania 19104 Not yet recruiting
UT Southwestern Dallas Texas 75390 Not yet recruiting
Univ Texas HSC-Houston Houston Texas 77030 Not yet recruiting
UT Health San Antonio San Antonio Texas 78229 Not yet recruiting
University of Utah Health Salt Lake City Utah 84106 Not yet recruiting
University of Vermont Med Ctr Burlington Vermont 05401 Not yet recruiting
University of Virginia Charlottesville Virginia 22903 Not yet recruiting
Virginia Cwealth Univ Richmond Richmond Virginia 23298 Not yet recruiting
Washington Ctr Bleed Disorder Seattle Washington 98195 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 65 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07830732, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 28, 2026 · Synced Nov 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.